KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Neogenomics (NEO) over the last 13 years, with Q4 2025 value amounting to 0.14%.

  • Neogenomics' Return on Invested Capital fell 400.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.13% for FY2025, which is 300.0% down from last year.
  • Neogenomics' Return on Invested Capital amounted to 0.14% in Q4 2025, which was down 400.0% from 0.14% recorded in Q3 2025.
  • Neogenomics' 5-year Return on Invested Capital high stood at 0.01% for Q1 2021, and its period low was 0.15% during Q3 2022.
  • Its 5-year average for Return on Invested Capital is 0.11%, with a median of 0.11% in 2022.
  • In the last 5 years, Neogenomics' Return on Invested Capital crashed by -1200bps in 2022 and then skyrocketed by 500bps in 2023.
  • Quarter analysis of 5 years shows Neogenomics' Return on Invested Capital stood at 0.06% in 2021, then tumbled by -142bps to 0.14% in 2022, then rose by 27bps to 0.1% in 2023, then rose by 4bps to 0.1% in 2024, then plummeted by -37bps to 0.14% in 2025.
  • Its Return on Invested Capital stands at 0.14% for Q4 2025, versus 0.14% for Q3 2025 and 0.13% for Q2 2025.